Five Rivers RX
  • Home
  • Free Consultation
  • Clients
    • Manufacturers
    • Distributors
      • Drug, Device, and Supply Distributors
      • External Distributors
    • Logistics
    • Providers & Dispensers
  • Services
    • Business Strategy & Consulting
    • Certified Designated Representative Training Courses
    • DEA Compliance
    • FDA Reporting
    • NABP Drug Distributor Accreditation (VAWD)
    • Puerto Rico Services
    • State Compliance Services
      • Initial Assessment
      • Obtaining New Licenses
      • On-going Renewals
      • Quality & Compliance Support
  • Company
    • Leadership
    • Team
    • Careers
    • Testimonials & Accolades
  • Resources
    • Assessments
    • State Regulatory Agencies
    • Webinars
    • Courses
  • Industry Insight & Blog
  • Contact Us
    • Contact Us
    • Our Locations
Select Page
Consolidation is on the Horizon for 503Bs and WDDs

Consolidation is on the Horizon for 503Bs and WDDs

by Five Rivers Rx | Jan 30, 2020 | Compounding Quality Act

The pharmaceutical industry has been notorious for consolidation and vertical integration over the last decade – and we can now expect another wave across two different business models. 503B Most of the content you see from Five Rivers RX in regards to the DQSA...
VDIP Accreditation Awarded for the First Time + the Program’s History

VDIP Accreditation Awarded for the First Time + the Program’s History

by Five Rivers Rx | Jan 29, 2020 | VDIP

Background of the VDIP® Program The Accreditation is the first to be awarded since the Verified- Accredited Device Integrity Program® (VDIP®) was launched on September 23, 2016. Per the website, the VDIP® Program was created to regulate “OTC medical device...

Recent Posts

  • Proposed Rules for DEA Suspicious Orders
  • Industry Comments on Iowa’s Drug Distributor Accreditation Requirement
  • NavigateSOM Releases User Manual
  • Retail Pharmacy Headwinds: New Technology & Disruption
  • Five Rivers RX Submits Comments on New PR Rule

Archives

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016

Categories

  • Competition
  • Compounding Quality Act
  • DEA
  • Drug Importation
  • Drug Manufacturers
  • Five Rivers
  • Industry News
  • NABP
  • NavigateSOM
  • Optum Rx
  • Puerto Rico
  • Regulations
  • Suspicious Order Monitoring
  • Uncategorized
  • VAWD
  • VDIP

Contact Us

 

705 Montgomery Ave., Suite 200
Penn Valley, PA 19072

E: hello@fiveriversrx.com
P: 800.962.8760

Socialize

  • Follow
  • Follow

Subscribe to Our Newsletter

Success!

Subscribe

© 2020 – Five Rivers RX – All rights reserved

 

Subscribe to Our Newsletter